---
title: "CI: Q2 2026 delivered 7% revenue growth and a raised 2026 outlook, driven by healthcare and health services"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294365547.md"
description: "Second quarter 2026 saw 7% revenue growth and a 6% rise in adjusted income from operations, with strong performance in both Evernorth and Cigna Healthcare segments. The 2026 outlook was raised, and the company announced a planned exit from the Individual and Family Plans business.Original document: The Cigna Group [CI] SEC 8-K Current Report — Jul. 30 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-30T12:27:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294365547.md)
  - [en](https://longbridge.com/en/news/294365547.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294365547.md)
generator: "portal-rs"
---

# CI: Q2 2026 delivered 7% revenue growth and a raised 2026 outlook, driven by healthcare and health services

Second quarter 2026 saw 7% revenue growth and a 6% rise in adjusted income from operations, with strong performance in both Evernorth and Cigna Healthcare segments. The 2026 outlook was raised, and the company announced a planned exit from the Individual and Family Plans business.

Original document: The Cigna Group \[CI\] SEC 8-K Current Report — Jul. 30 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [CI.US](https://longbridge.com/en/quote/CI.US.md)

## Related News & Research

- [If You Invested $100 In Cigna Group Stock 20 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/297812869.md)
- [How Is The Cigna Group’s Stock Performance Compared to Other Healthcare Plans](https://longbridge.com/en/news/297776351.md)
- [CRET: Q2 2026 saw higher sales and improved margins, but growth is limited by financing constraints](https://longbridge.com/en/news/297468890.md)
- [Igua Sergipe board signs off Q2 2026 financial results](https://longbridge.com/en/news/297932404.md)
- [Abbott Laboratories Stock: Is ABT Underperforming the Healthcare Sector?](https://longbridge.com/en/news/297586976.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**